A propolis composition for treating diabetes and its retinopathy and a method of preparing the same

By using an innovative formula and preparation method combining propolis and traditional Chinese medicine, the problems of low utilization of propolis components and low efficiency of traditional preparations have been solved, achieving a significant effect of highly effective treatment of diabetic retinopathy while avoiding interference from chemical additives.

CN122208680APending Publication Date: 2026-06-16HENGXIUTANG PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
HENGXIUTANG PHARM CO LTD
Filing Date
2026-03-26
Publication Date
2026-06-16

AI Technical Summary

Technical Problem

Existing propolis components have low bioavailability and limited target sites. Traditional compound preparations have low extraction efficiency of active ingredients, lack targeted compatibility, and have complex production processes. Western medicine has limited efficacy and side effects in treating diabetic retinopathy.

Method used

Using propolis as the main raw material, combined with Astragalus membranaceus, Rehmannia glutinosa, Cuscuta chinensis, Broussonetia papyrifera, Cistanche deserticola, Bombyx mori, Cicadae periostracum, Morus alba leaves, and Haliotis diversicolor, a propolis composition is prepared by low-temperature drying and ethanol extraction combined with water decoction. The composition is then made into tablets, capsules, or pills, avoiding the addition of excipients and ensuring the high concentration and stability of active ingredients.

Benefits of technology

It achieves multi-target and multi-pathway therapeutic effects, significantly reduces blood sugar, has anti-inflammatory and antioxidant effects, improves retinal microvessels, increases the retention rate of flavonoid components, simplifies the production process, ensures significant efficacy, and has no interference from chemical additives.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The application discloses a propolis composition for treating diabetes and retinopathy thereof and a preparation method thereof, wherein the propolis composition for treating diabetes and retinopathy thereof comprises the following components: propolis 0.1-0.5 parts, radix astragali 15-25 parts, radix rehmanniae preparata 15-25 parts, semen cocculus 40-60 parts, fructus broussonetiae 15-25 parts, herba cistanche 10-20 parts, cantharis 8-12 parts, periostracium of cicada 4-8 parts, folium mori 8-12 parts and concha murex 8-12 parts. The application plays a multi-target synergistic effect by compounding propolis and traditional Chinese medicines, significantly reduces fasting blood glucose, and improves retinal microcirculation.
Need to check novelty before this filing date? Find Prior Art